chevron_leftBack
As of 6 June 2026, Quratis Inc. has a market cap of $58.54M USD, ranking #29449 globally and #1616 in South Korea.
It ranks #2669 in the Healthcare sector, and #513 in the Biotechnology industry.
Key Stats
Market Cap
$58.54MUSD
89.72B KRW
Enterprise Value
$58.63MUSD
89.87B KRW
Revenue (TTM)
$1.6MUSD
2.46B KRW
EBITDA (TTM)
-$3.87MUSD
-5.93B KRW
Net Income (TTM)
-$19.36MUSD
-29.67B KRW
EBITDA Margin
-241%
PS Ratio
36.5
PB Ratio
2.0
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Biotechnology
CEO
Sung-Joon Kim
open_in_new
Founded
2016
Website
quratis.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 0.2% | -9.8% | -18% | -20% | -9.3% | -18% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
348080
(주)큐라티스
ISIN: KR7348080003
Shares Out.:
Shares Outstanding:
115.45M1
Shares Float:
45.853M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
850 KRW |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Quratis Inc.
Quratis Inc. engages in developing vaccines in South Korea. It is involved in developing QTP101, a vaccine for tuberculosis; QTP104, a next-generation mRNA vaccine; CPP (Cell Penetrating Peptide) Platform, a cell and bacterial penetration peptide drug delivery platform technology; and Peptide Nucleic Acid (PNA), a synthetic analogue of DNA in which the deoxyribose phosphate backbone. The company also offers drugs contract development and manufacturing services. Quratis Inc. was incorporated in 2016 and is based in Cheongju-si, South Korea.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
KRX: 207940
|
$44.48B
76K%
68.19T KRW
|
35.5
|
|
KRX: 068270
|
$27.89B
48K%
42.76T KRW
|
43.8
|
|
KRX: 196170
|
$13.27B
23K%
20.33T KRW
|
146.6
|
|
KRX: 028300
|
$5.46B
9K%
8.37T KRW
|
-
|
|
KRX: 087010
|
$3.96B
7K%
6.07T KRW
|
-
|
|
KRX: 302440
|
$2.23B
4K%
3.42T KRW
|
-
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NASDAQ: AMGN
|
$182.42B
312K%
|
23.9
|
|
NASDAQ: GILD
|
$159.92B
273K%
|
19.0
|
|
EBR: ARGX
|
$48.08B
82K%
41.39B EUR
|
39.9
|
|
ASX: CSL
|
$43.01B
73K%
60.27B AUD
|
29.3
|
|
SIX: LONN
|
$42.72B
73K%
33.71B CHF
|
37.2
|
|
NASDAQ: NTRA
|
$27.6B
47K%
|
-
|
chevron_leftBack